Physician profile
Ellen Manos
NPI 1538149356
$3,194.71
in general payments reported to CMS, 2019-2025
21 companies · $509 in 2025
The $509 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $180 · 2021: $348 · 2022: $429 · 2023: $534 · 2024: $488 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $956 · Education: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.62 |
| Education | $574.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $911.56 | 2023-2025 | Veozah |
| Pfizer INC. | $552.95 | 2019-2024 | |
| Therapeuticsmd, INC. | $358.87 | 2019-2021 | |
| Abbvie INC. | $229.95 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $161.54 | 2019-2020 | |
| Millicent US INC | $157.99 | 2020-2025 | Intrarosa, Femlyv |
| Scynexis, INC. | $147.94 | 2022 | |
| Exact Sciences Corporation | $103.12 | 2023-2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $90.27 | 2019-2023 | Divigel |
| Vertical Pharmaceuticals, LLC | $83.54 | 2019 | |
| Mayne Pharma Commercial LLC | $82.32 | 2022 | |
| Aspira Women'S Health INC | $56.93 | 2022 | |
| Sumitomo Pharma America, INC. | $49.09 | 2024-2025 | Myfembree |
| Agile Therapeutics, INC. | $41.32 | 2023 | Twirla |
| Hologic Sales and Service, LLC | $40.58 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $32.13 | 2021-2022 | |
| Bausch Health US, LLC | $24.93 | 2022 | |
| Evofem Biosciences, INC. | $19.51 | 2021 | |
| Duchesnay USA Incorporated | $17.57 | 2019 | |
| Ascend Therapeutics US, LLC | $16.60 | 2022 | |
| Coopersurgical, INC. | $16.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Manos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.